Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment

By  

Current Medicinal Chemistry, Vol. 20, Iss. 2, 2013-01 ,pp. : 167-185

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological inhibition of histone deacetylases for the treatment of cancer, neurodegenerative disorders and inflammatory diseases

By Bonfils Claire   Walkinshaw Donald R   Besterman Jeffrey M   Yang Xiang-Jiao   Li Zuomei  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 9, 2008-09 ,pp. : 1041-1065

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-02 ,pp. : 257-271

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Histone Deacetylase Inhibition for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 4, Iss. 2, 2004-03 ,pp. : 205-218

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibition in the treatment of heart disease

By Berry Jeff M   Cao Dian J   Rothermel Beverly A   Hill Joseph A  

Expert Opinion on Drug Safety, Vol. 7, Iss. 1, 2008-01 ,pp. : 53-67

Informa Healthcare

Access to resources Recommend Favorite